John Guy is named as a lobbyist on federal disclosure filings for 4 clients through Novel Strategies (fka) Prism Group. The most recent filing naming them posted in October 2026. Issues reported include Health Issues, Budget/Appropriations and Copyright/Patent/Trademark.
Filers must list covered executive or legislative branch positions held. As filed:
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| MASSACHUSETTS BIOTECHNOLOGY COUNCIL | NOVEL STRATEGIES (FKA) PRISM GROUP | Q3 2026 | Health Issues |
| GENEVANT SCIENCES, INC. | NOVEL STRATEGIES (FKA) PRISM GROUP | Q3 2026 | Health Issues, Copyright/Patent/Trademark |
| THE ALLIANCE FOR LONGEVITY INITIATIVES | NOVEL STRATEGIES (FKA) PRISM GROUP | Q3 2026 | Medical/Disease Research/Clinical Labs, Health Issues, Budget/Appropriations |
| INCUBATE | NOVEL STRATEGIES (FKA) PRISM GROUP | Q3 2026 | Health Issues |
| Year | Clients | Registrants |
|---|---|---|
| 2026 | 4 | 1 |
| 2025 | 2 | 1 |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name John Guy. See the Capitol Clarity rankings and method.